Detailed financial statements for The Clorox Company (CLX): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year: ten fiscal years free and up to 20 with Premium.
The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409.
Analysis Summary
The Clorox Company reported revenue of $6.72B in the most recent fiscal year, growing at a 5-year CAGR of -1.8%. Net income reached $587.0M, with a -3.7% 5-year CAGR.
Trailing-twelve-month margins: gross margin 42.3%, operating margin 24.7%, net margin 8.7%. Free cash flow grew at -15.6% CAGR over 5 years.
At $88.00 (closing price, October 30, 2026), CLX trades at a P/E of 18.30 and an ROE of -18.94%. Market capitalisation stands at $10.6B, placing it among large-cap names.
Balance sheet quality for CLX: current ratio of 0.7, net debt of $5.38B. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is below average: free cash flow of $405.0M represents 69% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Income Statement (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.97B | $6.12B | $6.21B | $6.72B | $7.34B | $7.11B | $7.39B | $7.09B | $7.10B | $6.72B |
| Cost of Revenue | $3.30B | $3.45B | $3.49B | $3.66B | $4.14B | $4.56B | $4.48B | $4.04B | $3.89B | $3.88B |
| Gross Profit | $2.67B | $2.67B | $2.73B | $3.06B | $3.20B | $2.54B | $2.91B | $3.05B | $3.21B | $2.84B |
| Research & Development | $135.0M | $132.0M | $136.0M | $145.0M | $149.0M | $132.0M | $138.0M | $126.0M | $121.0M | $116.0M |
| Selling, General & Admin | $1.41B | $1.41B | $1.47B | $1.64B | $1.79B | $1.66B | $1.92B | $2.17B | $1.89B | $1.07B |
| Operating Expenses | $1.55B | $1.55B | $1.62B | $1.80B | $1.97B | $1.83B | $2.08B | $2.33B | $2.04B | $1.18B |
| Operating Income | $1.12B | $1.12B | $1.11B | $1.26B | $1.23B | $719.0M | $823.0M | $723.0M | $1.18B | $1.66B |
| EBITDA | $1.28B | $1.30B | $1.30B | $1.46B | $1.21B | $937.0M | $564.0M | $723.0M | $1.39B | $921.0M |
| Interest Expense | $88.0M | $85.0M | $97.0M | $99.0M | $99.0M | $106.0M | $90.0M | $90.0M | $88.0M | $130.0M |
| Pre-tax Income | $1.03B | $1.05B | $1.02B | $1.19B | $900.0M | $607.0M | $238.0M | $398.0M | $1.08B | $791.0M |
| Income Tax | $330.0M | $231.0M | $204.0M | $246.0M | $181.0M | $136.0M | $77.0M | $106.0M | $254.0M | $190.0M |
| Net Income | $701.0M | $823.0M | $820.0M | $939.0M | $710.0M | $462.0M | $149.0M | $280.0M | $810.0M | $587.0M |
| EPS | $5.43 | $6.37 | $6.42 | $7.46 | $5.65 | $3.75 | $1.21 | $2.25 | $6.56 | $4.82 |
| EPS (Diluted) | $5.33 | $6.25 | $6.32 | $7.35 | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 | $4.81 |
| Shares Outstanding (Diluted) | 131.6 M | 131.6 M | 129.8 M | 127.7 M | 127.3 M | 123.9 M | 124.2 M | 124.8 M | 124.3 M | 122.1 M |
Income Statement (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Revenue | $1.43B | $1.67B | $1.67B | $1.95B |
| Gross Profit | $596.0M | $722.0M | $722.0M | $804.0M |
| Operating Income | $120.0M | $236.0M | $284.0M | $1.02B |
| EBITDA | $186.0M | $295.0M | $341.0M | $346.0M |
| Net Income | $80.0M | $157.0M | $187.0M | $163.0M |
| EPS | $0.65 | $1.29 | $1.54 | $1.34 |
| EPS (Diluted) | $0.65 | $1.29 | $1.54 | $1.33 |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $418.0M | $131.0M | $111.0M | $871.0M | $319.0M | $183.0M | $367.0M | $202.0M | $167.0M | $143.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $565.0M | $600.0M | $631.0M | $648.0M | $604.0M | $681.0M | $688.0M | $695.0M | $821.0M | $791.0M |
| Inventory | $459.0M | $506.0M | $512.0M | $454.0M | $752.0M | $755.0M | $696.0M | $637.0M | $523.0M | $777.0M |
| Total Current Assets | $1.51B | $1.31B | $1.30B | $2.02B | $1.83B | $1.73B | $1.83B | $1.62B | $1.61B | $1.82B |
| Property, Plant & Equipment | $931.0M | $996.0M | $1.03B | $1.39B | $1.63B | $1.68B | $1.69B | $1.68B | $1.60B | $1.91B |
| Goodwill | $1.20B | $1.60B | $1.59B | $1.58B | $1.57B | $1.56B | $1.25B | $1.23B | $1.23B | $1.95B |
| Intangible Assets | $722.0M | $929.0M | $912.0M | $894.0M | $918.0M | $884.0M | $712.0M | $681.0M | $566.0M | $606.0M |
| Total Assets | $4.57B | $5.06B | $5.12B | $6.21B | $6.33B | $6.16B | $5.95B | $5.75B | $5.56B | $7.79B |
| Accounts Payable | $501.0M | $507.0M | $507.0M | $575.0M | $930.0M | $960.0M | $1.02B | $950.0M | $838.0M | $1.60B |
| Short-term Debt | $804.0M | $199.0M | $396.0M | 0 | $300.0M | $237.0M | $50.0M | $4.0M | $4.0M | $1.09B |
| Total Current Liabilities | $1.81B | $1.20B | $1.44B | $1.42B | $2.06B | $1.78B | $1.92B | $1.57B | $1.92B | $2.77B |
| Long-term Debt | $1.39B | $2.28B | $2.29B | $2.78B | $2.48B | $2.47B | $2.48B | $2.48B | $2.48B | $3.98B |
| Total Liabilities | $4.03B | $4.33B | $4.56B | $5.30B | $5.74B | $5.43B | $5.56B | $5.26B | $5.08B | $7.54B |
| Retained Earnings | $2.44B | $2.80B | $3.15B | $3.57B | $1.04B | $1.05B | $583.0M | $250.0M | $432.0M | $386.0M |
| Total Equity | $542.0M | $726.0M | $559.0M | $908.0M | $411.0M | $556.0M | $220.0M | $328.0M | $321.0M | $90.0M |
| Total Debt | $2.19B | $2.48B | $2.68B | $3.12B | $3.17B | $3.10B | $2.92B | $2.90B | $2.88B | $5.52B |
| Net Debt | $1.78B | $2.35B | $2.57B | $2.25B | $2.85B | $2.92B | $2.56B | $2.70B | $2.71B | $5.38B |
| Working Capital | -$295.0M | $111.0M | -$135.0M | $602.0M | -$227.0M | -$59.0M | -$89.0M | $48.0M | -$311.0M | -$949.0M |
Balance Sheet (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Cash & Equivalents | $166.0M | $227.0M | $1.19B | $143.0M |
| Total Assets | $5.53B | $5.61B | $6.44B | $7.79B |
| Total Liabilities | $5.39B | $5.58B | $6.34B | $7.54B |
| Total Equity | -$22.0M | -$125.0M | -$67.0M | $90.0M |
| Total Debt | $3.08B | $3.22B | $4.49B | $5.52B |
Cash Flow (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $703.0M | $823.0M | $820.0M | $939.0M | $719.0M | $471.0M | $161.0M | $292.0M | $824.0M | $601.0M |
| Depreciation & Amortization | $163.0M | $166.0M | $180.0M | $180.0M | $211.0M | $224.0M | $236.0M | $235.0M | $219.0M | $247.0M |
| Stock-based Compensation | $51.0M | $53.0M | $43.0M | $50.0M | $50.0M | $52.0M | $73.0M | $74.0M | $81.0M | $48.0M |
| Change in Working Capital | -$47.0M | -$88.0M | -$2.0M | $349.0M | -$11.0M | -$99.0M | $354.0M | -$241.0M | -$211.0M | $118.0M |
| Operating Cash Flow | $868.0M | $974.0M | $992.0M | $1.55B | $1.28B | $786.0M | $1.16B | $695.0M | $981.0M | $612.0M |
| Capital Expenditure | -$231.0M | -$194.0M | -$206.0M | -$254.0M | -$331.0M | -$251.0M | -$228.0M | -$212.0M | -$220.0M | -$207.0M |
| Acquisitions | 0 | -$681.0M | 0 | 0 | -$85.0M | 0 | 0 | $17.0M | $128.0M | -$2.10B |
| Stock Repurchased | -$183.0M | -$271.0M | -$661.0M | -$248.0M | -$905.0M | -$25.0M | 0 | 0 | -$332.0M | -$256.0M |
| Dividends Paid | -$412.0M | -$450.0M | -$490.0M | -$533.0M | -$558.0M | -$571.0M | -$583.0M | -$595.0M | -$602.0M | -$602.0M |
| Free Cash Flow | $637.0M | $780.0M | $786.0M | $1.29B | $945.0M | $535.0M | $930.0M | $483.0M | $761.0M | $405.0M |
Cash Flow (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Operating Cash Flow | $93.0M | $311.0M | -$122.0M | $330.0M |
| Capital Expenditure | -$36.0M | -$42.0M | -$43.0M | -$86.0M |
| Free Cash Flow | $57.0M | $269.0M | -$165.0M | $244.0M |
| Dividends Paid | -$151.0M | -$151.0M | -$150.0M | -$150.0M |
| Stock-based Compensation | $10.0M | 0 | $39.0M | -$1.0M |
Growth & Margins (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth (YoY) | +2.5% | +1.5% | +8.2% | +9.2% | -3.2% | +4.0% | -4.0% | +0.2% | -5.4% | |
| Net Income Growth (YoY) | +17.4% | -0.4% | +14.5% | -24.4% | -34.9% | -67.7% | +87.9% | +189.3% | -27.5% | |
| EPS Growth (YoY) | +17.3% | +0.8% | +16.2% | -24.3% | -33.6% | -67.7% | +86.0% | +191.6% | -26.5% | |
| Shares Change (YoY) | +0.0% | -1.4% | -1.6% | -0.3% | -2.7% | +0.2% | +0.5% | -0.4% | -1.7% | |
| FCF Growth (YoY) | +22.4% | +0.8% | +64.4% | -26.9% | -43.4% | +73.8% | -48.1% | +57.6% | -46.8% | |
| Gross Margin | 44.7% | 43.7% | 43.9% | 45.6% | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% | 42.3% |
| Operating Margin | 18.7% | 18.4% | 17.8% | 18.8% | 16.7% | 10.1% | 11.1% | 10.2% | 16.6% | 24.7% |
| EBITDA Margin | 21.5% | 21.3% | 20.9% | 21.8% | 16.5% | 13.2% | 7.6% | 10.2% | 19.5% | 13.7% |
| Net Margin | 11.7% | 13.4% | 13.2% | 14.0% | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% | 8.7% |
| FCF Margin | 10.7% | 12.7% | 12.6% | 19.2% | 12.9% | 7.5% | 12.6% | 6.8% | 10.7% | 6.0% |
| Effective Tax Rate | 31.9% | 21.9% | 19.9% | 20.8% | 20.1% | 22.4% | 32.4% | 26.6% | 23.6% | 24.0% |
Per-Share Data (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF Per Share | $4.84 | $5.93 | $6.06 | $10.12 | $7.42 | $4.32 | $7.49 | $3.87 | $6.12 | $3.32 |
| Dividends Per Share | $3.13 | $3.42 | $3.78 | $4.17 | $4.38 | $4.61 | $4.69 | $4.77 | $4.84 | $4.93 |
| Shares Outstanding (Basic) | 129.0 M | 129.3 M | 127.7 M | 125.8 M | 125.6 M | 123.1 M | 123.6 M | 124.2 M | 123.5 M | 121.8 M |
What to look at in Consumer Defensive companies
- Gross margin (stable 5y) (Stable >=35%) — Brand pricing power — Coca-Cola does not drop margins.
- ROE / ROIC stable (ROE >=15% stable) — Defensive businesses have high consistent ROEs — Lynch's stalwarts.
- FCF / Net Income (>=90%) — Earnings to cash conversion — best names exceed 95%.
- Dividend growth 10y (>=6%/year) — Dividend Aristocrats raise 25+ years — moat signal.
- Payout Ratio (<75%) — >80% = dividend at risk. <60% comfortable.
- Net Debt / EBITDA (<2.5x) — Defensive with high debt loses its essence.
Profitability
| Return on Equity | -1,893.55% |
| Return on Invested Capital | 20.39% |
| Return on Assets | 7.53% |
| Gross Margin | 42.32% |
| Operating Margin | 24.73% |
| Net Margin | 8.74% |
Financial Health
| Debt / Equity | 61.33 |
| Current Ratio | 0.66 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 2.41 |
Key Ratios (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | 24.54 | 21.23 | 23.80 | 29.41 | 31.84 | 37.59 | 131.44 | 59.66 | 18.30 | 19.80 |
| P/B | 31.70 | 24.09 | 34.92 | 30.40 | 54.97 | 31.22 | 89.34 | 50.82 | 46.20 | 129.14 |
| P/S | 2.88 | 2.86 | 3.14 | 4.11 | 3.08 | 2.44 | 2.66 | 2.35 | 2.09 | 1.73 |
| Gross Margin | 44.7% | 43.7% | 43.9% | 45.6% | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% | 42.3% |
| Operating Margin | 18.7% | 18.4% | 17.8% | 18.8% | 16.7% | 10.1% | 11.1% | 10.2% | 16.6% | 24.7% |
| Net Margin | 11.7% | 13.4% | 13.2% | 14.0% | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% | 8.7% |
Related companies: KMB · REYN · PG · UL · CL · KVUE · CHD
Explore sector: Consumer Defensive · Household & Personal Products
More sections of CLX: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks